BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 30251441)

  • 1. Ruthenaelectro-Catalyzed Domino Three-Component Alkyne Annulation for Expedient Isoquinoline Assembly.
    Tan X; Hou X; Rogge T; Ackermann L
    Angew Chem Int Ed Engl; 2021 Feb; 60(9):4619-4624. PubMed ID: 33270973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly of Heterocyclic C-Glycosides by Ru-Catalyzed C-H Activation/Cyclization with Carbonyl Sulfoxonium Ylide Glyco-Reagents.
    Liu DY; Wang PF; Ruan YJ; Wang XL; Hu XY; Yang Q; Liu J; Wen MM; Zhang CZ; Xiao YH; Liu XG
    Org Lett; 2024 Jun; 26(24):5092-5097. PubMed ID: 38848493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies of the palladium-catalyzed S,O-ligand promoted C-H olefination of aromatic compounds.
    Naksomboon K; Gómez-Bengoa E; Mehara J; Roithová J; Otten E; Fernández-Ibáñez MÁ
    Chem Sci; 2023 Mar; 14(11):2943-2953. PubMed ID: 36937590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ruthenium-catalyzed cascade C-H activation/annulation of
    Song L; Zhang X; Tang X; Van Meervelt L; Van der Eycken J; Harvey JN; Van der Eycken EV
    Chem Sci; 2020 Sep; 11(42):11562-11569. PubMed ID: 34094402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium(II)-Catalyzed Homocoupling of α-Carbonyl Sulfoxonium Ylides Under Mild Conditions: Methodology Development and Mechanistic DFT Study.
    Zhang M; Zhang J; Teng Z; Chen J; Xia Y
    Front Chem; 2020; 8():648. PubMed ID: 33195001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruthenium(ii)-catalyzed chemoselective deacylative annulation of 1,3-diones with sulfoxonium ylides
    Wen S; Lv W; Ba D; Liu J; Cheng G
    Chem Sci; 2019 Oct; 10(39):9104-9108. PubMed ID: 31827753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemospecific Cyclizations of α-Carbonyl Sulfoxonium Ylides on Aryls and Heteroaryls.
    Clare D; Dobson BC; Inglesby PA; Aïssa C
    Angew Chem Int Ed Engl; 2019 Nov; 58(45):16198-16202. PubMed ID: 31507055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the multifaceted applications of vinyl sulfoxonium ylides.
    Sen R; Bhardwaj S; Bar K; Deshwal S; Vaitla J
    Chem Commun (Camb); 2023 Oct; 59(83):12411-12422. PubMed ID: 37753776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manganese-Oxygen Intermediates in O-O Bond Activation and Hydrogen-Atom Transfer Reactions.
    Rice DB; Massie AA; Jackson TA
    Acc Chem Res; 2017 Nov; 50(11):2706-2717. PubMed ID: 29064667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruthenium(IV) Intermediates in C-H Activation/Annulation by Weak O-Coordination.
    Liang YF; Yang L; Rogge T; Ackermann L
    Chemistry; 2018 Nov; 24(62):16548-16552. PubMed ID: 30251441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distal Weak Coordination of Acetamides in Ruthenium(II)-Catalyzed C-H Activation Processes.
    Bu Q; Rogge T; Kotek V; Ackermann L
    Angew Chem Int Ed Engl; 2018 Jan; 57(3):765-768. PubMed ID: 29141119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amidines for versatile ruthenium(II)-catalyzed oxidative C-H activations with internal alkynes and acrylates.
    Li J; John M; Ackermann L
    Chemistry; 2014 Apr; 20(18):5403-8. PubMed ID: 24677682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micellar Catalysis for Ruthenium(II)-Catalyzed C-H Arylation: Weak-Coordination-Enabled C-H Activation in H
    Yetra SR; Rogge T; Warratz S; Struwe J; Peng W; Vana P; Ackermann L
    Angew Chem Int Ed Engl; 2019 May; 58(22):7490-7494. PubMed ID: 30860636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrooxidative Ruthenium-Catalyzed C-H/O-H Annulation by Weak O-Coordination.
    Qiu Y; Tian C; Massignan L; Rogge T; Ackermann L
    Angew Chem Int Ed Engl; 2018 May; 57(20):5818-5822. PubMed ID: 29603565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxylate-assisted ruthenium-catalyzed alkyne annulations by C-H/Het-H bond functionalizations.
    Ackermann L
    Acc Chem Res; 2014 Feb; 47(2):281-95. PubMed ID: 23379589
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.